SARS-CoV-2 Spike-Specific T-Cell Responses in Patients With B-Cell Depletion Who Received Chimeric Antigen Receptor T-Cell Treatments.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34792539.
- Also identified by DOI 10.1001/jamaoncol.2021.6030 and PMC identifier 8603228.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines the ability of patients receiving chimeric antigen receptor T-cell treatments to mount T-cell immunity in response to messenger RNA vaccines for severe acute respiratory syndrome coronavirus 2 despite substantial B-cell depletion.
Medical subject headings
- COVID-19
- Immunotherapy, Adoptive
- Spike Glycoprotein, Coronavirus
- T-Lymphocytes